These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17030739)

  • 1. Structure of the human mitochondrial monoamine oxidase B: new chemical implications for neuroprotectant drug design.
    Binda C; Hubálek F; Li M; Castagnoli N; Edmondson DE; Mattevi A
    Neurology; 2006 Oct; 67(7 Suppl 2):S5-7. PubMed ID: 17030739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders.
    Binda C; Newton-Vinson P; Hubálek F; Edmondson DE; Mattevi A
    Nat Struct Biol; 2002 Jan; 9(1):22-6. PubMed ID: 11753429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures.
    Binda C; Li M; Hubalek F; Restelli N; Edmondson DE; Mattevi A
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9750-5. PubMed ID: 12913124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and mechanism of monoamine oxidase.
    Edmondson DE; Mattevi A; Binda C; Li M; Hubálek F
    Curr Med Chem; 2004 Aug; 11(15):1983-93. PubMed ID: 15279562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of isoleucine 199 as a structural determinant for the selective inhibition of human monoamine oxidase B by specific reversible inhibitors.
    Hubálek F; Binda C; Khalil A; Li M; Mattevi A; Castagnoli N; Edmondson DE
    J Biol Chem; 2005 Apr; 280(16):15761-6. PubMed ID: 15710600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 'gating' residues Ile199 and Tyr326 in human monoamine oxidase B function in substrate and inhibitor recognition.
    Milczek EM; Binda C; Rovida S; Mattevi A; Edmondson DE
    FEBS J; 2011 Dec; 278(24):4860-9. PubMed ID: 21978362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docking of novel reversible monoamine oxidase-B inhibitors: efficient prediction of ligand binding sites and estimation of inhibitors thermodynamic properties.
    Yelekçi K; Karahan O; Toprakçi M
    J Neural Transm (Vienna); 2007; 114(6):725-32. PubMed ID: 17401533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models.
    Mladenović M; Patsilinakos A; Pirolli A; Sabatino M; Ragno R
    J Chem Inf Model; 2017 Apr; 57(4):787-814. PubMed ID: 28291352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of human monoamine oxidase B, a drug target enzyme monotopically inserted into the mitochondrial outer membrane.
    Binda C; Hubálek F; Li M; Edmondson DE; Mattevi A
    FEBS Lett; 2004 Apr; 564(3):225-8. PubMed ID: 15111100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitor design for monoamine oxidases.
    Ramsay RR
    Curr Pharm Des; 2013; 19(14):2529-39. PubMed ID: 23116392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structures of monoamine oxidase B in complex with four inhibitors of the N-propargylaminoindan class.
    Binda C; Hubálek F; Li M; Herzig Y; Sterling J; Edmondson DE; Mattevi A
    J Med Chem; 2004 Mar; 47(7):1767-74. PubMed ID: 15027868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of monoamine oxidase by (E)-styrylisatin analogues.
    Van der Walt EM; Milczek EM; Malan SF; Edmondson DE; Castagnoli N; Bergh JJ; Petzer JP
    Bioorg Med Chem Lett; 2009 May; 19(9):2509-13. PubMed ID: 19342233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a single catalytic binding site on human brain type B monoamine oxidase.
    Roth JA
    J Neurochem; 1976 Nov; 27(5):1107-12. PubMed ID: 12170596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of monoamine oxidase by C5-substituted phthalimide analogues.
    Manley-King CI; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2011 Aug; 19(16):4829-40. PubMed ID: 21778064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine Oxidases.
    Edmondson DE; Binda C
    Subcell Biochem; 2018; 87():117-139. PubMed ID: 29464559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics, flexible docking, virtual screening, ADMET predictions, and molecular interaction field studies to design novel potential MAO-B inhibitors.
    Braun GH; Jorge DM; Ramos HP; Alves RM; da Silva VB; Giuliatti S; Sampaio SV; Taft CA; Silva CH
    J Biomol Struct Dyn; 2008 Feb; 25(4):347-55. PubMed ID: 18092829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
    Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
    Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural properties of human monoamine oxidases A and B.
    Binda C; Mattevi A; Edmondson DE
    Int Rev Neurobiol; 2011; 100():1-11. PubMed ID: 21971000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure of monoamine oxidases: past, present, and future.
    Iacovino LG; Magnani F; Binda C
    J Neural Transm (Vienna); 2018 Nov; 125(11):1567-1579. PubMed ID: 30167931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine oxidase inhibitory activity of methoxy-substituted chalcones.
    Mathew B; Mathew GE; Ucar G; Joy M; Nafna EK; Lohidakshan KK; Suresh J
    Int J Biol Macromol; 2017 Nov; 104(Pt A):1321-1329. PubMed ID: 28577983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.